Adenocyte FINAL
Manufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8 Ha-marpe Har Hotzvim St, Jerusalem, Je...Website
www.adenocyte.comRevenue
<$5 MillionIndustry
About Adenocyte FINAL
Adenocyte specializes in the early detection and prevention of pancreatic cancer through innovative technology. They utilize a unique, FDA-cleared low intensity, non-focused ultrasound (LINFU) to enhance the collection of cytological specimens for cancer screening. Their approach allows for non-invasive sampling of pancreatic ductal cells, significantly improving the quality of samples for dysplasia and cancer detection. The company aims to provide effective screening solutions for healthcare providers and patients at risk of pancreatic cancer.Explore more
SIC Code 38,382NAICS Code 33,339Show more
Adenocyte FINAL Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Adenocyte FINAL Tech Stack
A closer look at the technologies used by Adenocyte FINAL
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Adenocyte FINAL
Sign Up For FreeTo access detailed company insights
Adenocyte specializes in the early detection and prevention of pancreatic cancer through innovative technology. They utilize a unique, FDA-cleared low intensity, non-focused ultrasound (LINFU) to enhance the collection of cytological specimens for cancer screening. Their approach allows for non-invasive sampling of pancreatic ductal cells, signific... Read More
